Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPECT-cUTI: CXA-201 vs Levofloxacin in Complicated Urinary Tract Infection
NCT01345929Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of ceftolozane + tazobactam in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Merck & Co.. Started Jun 2011; status: completed.
02
Drugs
ceftolozane + tazobactam
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT01345929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345929.